SPC2996
Navigation Links
SPC2996 in Medical Technology
Bcl-2 Antagonist shown to be therapeutically effective in a
mouse model of Chronic Lymphocytic Leukaemia
COPENHAGEN, 18 April 2007 - Santaris Pharma, the Danish
biopharmaceutical company developing RNAi drugs, yesterday
presented encouraging data at the American Association for Cancer
Research A...
Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia
First RNA Antagonist Medicine to Be Tested in Patients Reduces Severity of Adult Leukaemia Copenhagen, 6th June 2007 - Santaris Pharma, the Danish biopharmaceutical company, announced today that SPC2996, the Company's new RNA Antagonist of Bcl-2, has shown early evidence of efficacy in an initia...SPC2996 in Biological Technology
Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
... own development activities within metabolic disorders and infectious diseases, it has been decided to divest the activities within the development of spc2996 targeting CLL. This process is ongoing. EZN3042-Survivin In February 2009 Santaris Pharma's collaboration partner Enzon Pharmaceuticals ...SPC2996 in other areas
News - FDA Approves IND for SPC2996 in Chronic Lymphocytic Leukaemia
SPC2996 is the first of a new class of LNA-based investigational drugs known as ... SPC2996 acts by inhibiting the synthesis of Bcl-2, a key intracellular protein ...Definition of oligonucleotide SPC2996 - National Cancer Institute Drug ...
The search textbox has an autosuggest feature. ... Oligonucleotide SPC2996 binds to and inactivates Bcl-2 mRNA, thereby inhibiting ...SPC2996 in Chronic Lymphocytic Leukaemia - Full Text View ...
SPC2996 in Chronic Lymphocytic Leukaemia. This study is ongoing, but not recruiting participants. ... Dose Escalating, Phase I/II Study of SPC2996,an LNA ...Investigational New Drug Application Approved for SPC2996 for Treatment ...
SPC2996 is an RNA antagonist that has been designed to reduce Bcl-2 protein ... II study is currently ongoing to evaluate SPC2996 in relapsed or refractory CLL. ...Santaris Pharma presents positive preclinical data on SPC2996 at the ...
SPC2996 was tested for anti-leukaemic activity over two weeks in this model ... Therapy with SPC2996 resulted in a 54% reduction (p=0.043) in the number of CLL ...Investigational New Drug application for SPC2996, which enabled ... These compounds, like SPC2996, have been ... SPC2996, under Good Manufacturing Practice ...
Other TagsUrostomyRiteRiteRiteRiteRiteLumiLumiLumiLumiLumiDLPEOPAOther Contentsfibrocysticfibrinfibrinfibrinfibrinfissurefibrinogenfibrinogenfibrinogenfibrillationfibrillationfibrillationfibrillationfibroidfibroidfifthfifthfifthfifthfifth
(Date:11/26/2009)...,, NEWYORK,Nov.27/PRNewswire/--Withcoldandflu...practicestocontrolthespreadofinfectionsandavoidill...lveshealthy,buttoavoidtransmittingillnessifwe,resi...on-control),nursingdirectorforinfectioncontrolando...nManhattan. ,, HospitalforSpecialSurgeryhasoneo...
(Date:11/26/2009)... The copper sequestering drug tetrathiomolybdate ...the treatment of Wilson disease, a disease caused ...ancers. That much is known. Very little, however, ... level. , A new study led by Northwestern Univer...ue: the three-dimensional structure of TM bound to...
(Date:11/26/2009)... No more letters from the...r,personalized text messages from Santa , ...ffort to increase operational efficiencies at the ...g to help keep children all over the globe informe...,Elves in Santa’s research department have i...
(Date:11/26/2009)... Benton Communications an...ness growth system for retailers struggling to mak... (PRWEB) November 26, 2009 -- Flu fears is the typ...s to the emergency room, according to Dr. David Be...ly released business growth system – The Rf...
(Date:11/25/2009)...,, KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBart...on,slargestmedicalcliniconDec.9-10,whenKansasCityh...uredpeople. ,, "Thisfreecliniceventhasthepotent...daysinsteadofjustoneandbeheldonweekdaysinsteadofov...CityFreeHealthClinicandpresidentoftheNationalAssoc...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2[1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use[1] Research sheds light on workings of anti-cancer drug[1] Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes[1] Pharmacist Injects Cure for Ailing Businesses [1] Kansas City Prepares for Largest Free Health Clinic
(Date:11/24/2009)...ed a protein that may help gut bacteria bind to th...d by probiotic producers to identify strains that ...obiotics need to interact with cells lining the gu...to surfaces in the gut they are more likely to sti...ys Dr Nathalie Juge from the Institute of Food Res...
(Date:11/24/2009)...College of Medical Toxicology (ACMT) have signed a...he Journal of Medical Toxicology (JMT), the offi... It was previously published by the University of...Toxicology , an international, peer-reviewed journ...tice of medical toxicology. The quarterly journal...
(Date:11/24/2009)...d is a matter of debate. A high-profile study a fe...ent of their carbon from trees and leaves, evidenc...d aquatic ecosystems. , But new research from th...y to be true. Algae provide a much richer diet for...h published this week in the Proceedings of the N...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3June 18 Conference Features Legal Medical 26 Scientific Presentations 47511 1June 18 Conference Features Legal Medical 26 Scientific Presentations 47511 2June 18 Conference Features Legal Medical 26 Scientific Presentations 47511 3Most common brain cancer may originate in neural stem cells 47510 1Most common brain cancer may originate in neural stem cells 47510 2Most common brain cancer may originate in neural stem cells 47510 3Most common brain cancer may originate in neural stem cells 47510 4When lawn mowers attack 47508 1When lawn mowers attack 47508 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |